SU1508956A3 - Способ получени производных фенилацетонитрила или гидратов, или дигидратов их оксалатов, или цитратов - Google Patents

Способ получени производных фенилацетонитрила или гидратов, или дигидратов их оксалатов, или цитратов Download PDF

Info

Publication number
SU1508956A3
SU1508956A3 SU853955485A SU3955485A SU1508956A3 SU 1508956 A3 SU1508956 A3 SU 1508956A3 SU 853955485 A SU853955485 A SU 853955485A SU 3955485 A SU3955485 A SU 3955485A SU 1508956 A3 SU1508956 A3 SU 1508956A3
Authority
SU
USSR - Soviet Union
Prior art keywords
found
calculated
methyl
methoxy
cyano
Prior art date
Application number
SU853955485A
Other languages
English (en)
Russian (ru)
Inventor
Ляйнерт Херберт
Кампе Вольфганг
Штрайн Клаус
Мюллер-Бекманн Бернд
Барч Вольфганг
Original Assignee
Берингер Маннхайм Гмбх (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Маннхайм Гмбх (Фирма) filed Critical Берингер Маннхайм Гмбх (Фирма)
Application granted granted Critical
Publication of SU1508956A3 publication Critical patent/SU1508956A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
SU853955485A 1984-09-12 1985-09-11 Способ получени производных фенилацетонитрила или гидратов, или дигидратов их оксалатов, или цитратов SU1508956A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843433383 DE3433383A1 (de) 1984-09-12 1984-09-12 Neue phenyl-acetonitril-derivate

Publications (1)

Publication Number Publication Date
SU1508956A3 true SU1508956A3 (ru) 1989-09-15

Family

ID=6245162

Family Applications (1)

Application Number Title Priority Date Filing Date
SU853955485A SU1508956A3 (ru) 1984-09-12 1985-09-11 Способ получени производных фенилацетонитрила или гидратов, или дигидратов их оксалатов, или цитратов

Country Status (16)

Country Link
US (1) US4612313A (enExample)
EP (1) EP0175249A3 (enExample)
JP (1) JPS6185355A (enExample)
AU (1) AU562730B2 (enExample)
CA (1) CA1248533A (enExample)
CS (1) CS255894B2 (enExample)
DD (1) DD237504A5 (enExample)
DE (1) DE3433383A1 (enExample)
DK (1) DK413685A (enExample)
ES (1) ES8604861A1 (enExample)
FI (1) FI853343L (enExample)
GR (1) GR852167B (enExample)
HU (1) HU195644B (enExample)
IL (1) IL76327A (enExample)
SU (1) SU1508956A3 (enExample)
ZA (1) ZA856942B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612329A (en) * 1984-10-17 1986-09-16 Hokuriku Pharmaceutical Co., Ltd. Pharmaceutical alpha-aminoalkyl-alpha-alkylphenylacetonitriles
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
US6263940B1 (en) 1999-04-21 2001-07-24 Axon Corporation In-line continuous feed sleeve labeling machine and method
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
JP5421908B2 (ja) 2007-06-20 2014-02-19 マイルストーン ファーマシューティカルズ インコーポレーテッド 短時間作用型フェニルアルキルアミンカルシウムチャネルブロッカーおよびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
US4340603A (en) * 1980-08-13 1982-07-20 Interx Research Corporation Novel inotropic prodrugs
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент DE № 1154810, кл. С 2 С, опублик. 1978. *

Also Published As

Publication number Publication date
HU195644B (en) 1988-06-28
AU4709985A (en) 1986-03-20
FI853343A0 (fi) 1985-08-30
EP0175249A3 (de) 1987-08-19
US4612313A (en) 1986-09-16
IL76327A (en) 1989-06-30
EP0175249A2 (de) 1986-03-26
ES546908A0 (es) 1986-03-16
ZA856942B (en) 1986-05-28
DK413685A (da) 1986-03-13
CS652285A2 (en) 1987-07-16
AU562730B2 (en) 1987-06-18
CA1248533A (en) 1989-01-10
JPS6185355A (ja) 1986-04-30
FI853343A7 (fi) 1986-03-13
DE3433383A1 (de) 1986-03-20
FI853343L (fi) 1986-03-13
DK413685D0 (da) 1985-09-11
DD237504A5 (de) 1986-07-16
ES8604861A1 (es) 1986-03-16
HUT38302A (en) 1986-05-28
GR852167B (enExample) 1986-01-03
IL76327A0 (en) 1986-01-31
CS255894B2 (en) 1988-03-15

Similar Documents

Publication Publication Date Title
US4400394A (en) Benzylidene derivatives
SU1156592A3 (ru) Способ получени производных аминопропанола или их солей
CA2134765A1 (en) Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
SU1588740A1 (ru) Гидрохлориды дифенилпропиламина, обладающие антиангинальной активностью
SU1508956A3 (ru) Способ получени производных фенилацетонитрила или гидратов, или дигидратов их оксалатов, или цитратов
RU2345061C2 (ru) Производные (2-аминофенил)-амида ариленкарбоновой кислоты как фармацевтические препараты
JP2009007258A (ja) Pai−1産生抑制作用を有する3−アニリノ−2−シクロアルケノン誘導体
CA1054151A (fr) Derives de la n-(trimethoxy-3,4,5 cinnamoyl) piperazine, leur procede de preparation et leur application en therapeutique
JPS58140050A (ja) 1−(2−プチリル−4−フルオロフエノキシ)−2−ヒドロキシ−3−第三ブチルアミノプロパンの製造法
JP2006503816A (ja) R型バンブテロール、合成と治療上の効用
EP0174242B1 (fr) Dérivés de 1-(aminophényl)-2-amino-propanone, leur utilisation en thérapeutique et leur procédé de préparation
SU1635899A3 (ru) Способ получени 3-[(1Н-имидазол-4-ил)метил]-2-оксибензолметанолов
US3965190A (en) Phenyl propanones
US3940387A (en) Yohimbine derivatives, process for their preparation and their applications
RU2081108C1 (ru) Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью
US3629443A (en) Therapeutic composition containing a mandelamidine derivative
US4603019A (en) N-(methoxyphenacyl)-amine derivatives
EP0138714B1 (fr) Dérivés de 1-(acétylaminophényl)-2-amino-propanone, leur utilisation en thérapeutique et leur procédé de préparation
US5317026A (en) Acetamide derivative and application thereof
US4988735A (en) Ethylene diamine active cardiovascular therapy
SU1421258A3 (ru) Способ получени транс-октагидрооксазоло(4,5 @ )хинолина или его фармацевтически приемлемых солей
PT90802B (pt) Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem
JP2779269B2 (ja) 不整脈治療におけるジアミン
SU1205758A3 (ru) Способ получени производных аминоэтанола или их солей
HK123396A (en) New bronchospasmolytic compounds and process for their preparation